Achieve life sciences to present at the jefferies global healthcare conference

Seattle and vancouver, british columbia, may 28, 2025 (globe newswire) -- achieve life sciences, inc. (nasdaq: achv), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence for smoking cessation, today announced that the company will present at the jefferies global healthcare conference being held june 3–5, 2025, in new york city.
ACHV Ratings Summary
ACHV Quant Ranking